GlassScriptPhysician profile
Stephen Lawler Hasak
NPI 1184063562
$81,231.30
in general payments reported to CMS, 2019-2025
26 companies · $6,520 in 2025
The $6,520 reported for 2025 was more than what 91% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $55K · 2020: $13K · 2021: $345 · 2022: $1,184 · 2023: $2,641 · 2024: $2,834 · 2025: $6,520.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,453 · Food and Beverage: $4,347 · Consulting Fee: $3,010 · Education: $186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,452.59 |
| Food and Beverage | $4,347.13 |
| Consulting Fee | $3,010.00 |
| Education | $185.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $42,581.51 | 2019-2022 | |
| Boston Scientific Corporation | $25,086.00 | 2019-2020 | |
| Conmed Corporation | $4,706.27 | 2022-2025 | Conmed Biliary, Conmed Generators, Conmed Dilation |
| Olympus Corporation of The Americas | $3,392.69 | 2023-2024 | Single Use Electrosurgical Knife Kd-655, Disposable Distal Attachment, Single Use Electrosurgical Hemostatic Forceps |
| Abbvie INC. | $1,173.53 | 2021-2025 | |
| Janssen Biotech, INC. | $1,172.68 | 2022-2025 | Tremfya, Stelara |
| Gilead Sciences, INC. | $726.00 | 2021-2025 | Epclusa |
| Ambu INC. | $390.46 | 2021-2022 | |
| Phathom Pharmaceuticals, INC. | $354.35 | 2025 | Voquezna |
| Janssen Scientific Affairs, LLC | $239.19 | 2024 | Stelara |
| Takeda Pharmaceuticals U.S.A., INC. | $227.68 | 2023-2025 | Gattex, Entyvio, Eohilia |
| Medtronic, INC. | $161.95 | 2022 | |
| Intercept Pharmaceuticals, INC. | $159.82 | 2022-2025 | |
| Mallinckrodt Hospital Products INC. | $128.68 | 2023 | Terlivaz |
| Covidien LP | $108.18 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ardelyx, INC. | $106.14 | 2023-2025 | Ibsrela |
| Celgene Corporation | $95.06 | 2023-2024 | Zeposia |
| Genzyme Corporation | $82.67 | 2024-2025 | |
| Celltrion USA INC. | $82.43 | 2024-2025 | Vegzelma, Zymfentra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $80.34 | 2022 | |
| Olympus America INC. | $61.19 | 2021 | |
| Ferring Pharmaceuticals INC. | $55.56 | 2022-2023 | Rebyota, Clenpiq |
| Lilly USA, LLC | $16.80 | 2025 | Omvoh |
| Pfizer INC. | $15.76 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $13.76 | 2024 | Dupixent |
| Apollo Endosurgery US INC | $12.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Hasak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.